CCNF
Gene Information
- Official Symbol: CCNF
- Official Name: cyclin F
- Aliases and Previous Symbols: N/A
- Entrez ID: 899
- UniProt: P41002
- Interactions: BioGRID
- PubMed articles: Open PubMed
- OMIM: Open OMIM
Function Summary
- Entrez Summary: N/A
- UniProt Summary: Substrate recognition component of a SCF (SKP1-CUL1-F- box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of CP110 during G2 phase, thereby acting as an inhibitor of centrosome reduplication. {ECO:0000269|PubMed:20596027}.
Pfam Domains GO Terms
Pfam Domains
| Cyclin N |
| F-box |
| Cyclin C |
GO Terms
| re-entry into mitotic cell cycle |
| negative regulation of centrosome duplication |
| negative regulation of centrosome cycle |
| cyclin-dependent protein kinase holoenzyme complex |
| cyclin-dependent protein serine/threonine kinase regulator activity |
| regulation of centrosome duplication |
| regulation of centrosome cycle |
| SCF ubiquitin ligase complex |
| SCF-dependent proteasomal ubiquitin-dependent protein catabolic process |
| regulation of cyclin-dependent protein serine/threonine kinase activity |
| regulation of cyclin-dependent protein kinase activity |
| negative regulation of cytoskeleton organization |
| centriole |
| placenta development |
| regulation of microtubule cytoskeleton organization |
| regulation of microtubule-based process |
| protein kinase activity |
| mitotic cell cycle phase transition |
| cell cycle phase transition |
| protein polyubiquitination |
| proteasome-mediated ubiquitin-dependent protein catabolic process |
| negative regulation of cell cycle process |
| proteasomal protein catabolic process |
| post-translational protein modification |
| negative regulation of organelle organization |
| reproductive structure development |
| reproductive system development |
| protein kinase binding |
| centrosome |
| cell division |
| regulation of protein serine/threonine kinase activity |
| ubiquitin-dependent protein catabolic process |
| modification-dependent protein catabolic process |
| regulation of cytoskeleton organization |
| modification-dependent macromolecule catabolic process |
| cell junction |
| negative regulation of cell cycle |
| proteolysis involved in cellular protein catabolic process |
| mitotic cell cycle process |
| cellular protein catabolic process |
| developmental process involved in reproduction |
| protein catabolic process |
| mitotic cell cycle |
| protein ubiquitination |
| negative regulation of cellular component organization |
| regulation of cell cycle process |
| protein modification by small protein conjugation |
| regulation of protein kinase activity |
| regulation of kinase activity |
| cellular macromolecule catabolic process |
| protein phosphorylation |
| regulation of transferase activity |
| protein modification by small protein conjugation or removal |
| cell cycle process |
| macromolecule catabolic process |
| organonitrogen compound catabolic process |
| regulation of cell cycle |
| proteolysis |
| phosphorylation |
| regulation of organelle organization |
| cell cycle |
| reproductive process |
| reproduction |
| regulation of protein phosphorylation |
| regulation of phosphorylation |
| organic substance catabolic process |
| regulation of phosphate metabolic process |
| regulation of phosphorus metabolic process |
| cellular catabolic process |
| regulation of protein modification process |
CRISPR Data
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Compound Hit
Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Global Fraction of Cell Lines Where Essential: 1/739
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 0/28 |
| bone | 0/26 |
| breast | 0/33 |
| central nervous system | 0/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 0/75 |
| lymphocyte | 0/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 0/15 |
| prostate | 0/1 |
| skin | 1/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 0/29 |
| uterus | 0/5 |
Essentiality in NALM6
- Essentiality Rank: 2063
- Expression level (log2 read counts): 7.14
Expression Distribution
CCNF Expression in NALM6 Cells: 7.14